Niox Group (NIOX)

Sector:

Health Care

Index:

FTSE AIM 50

68.80p
   
  • Change Today:
    -3.20p
  • 52 Week High: 76.00p
  • 52 Week Low: 57.80p
  • Currency: UK Pounds
  • Shares Issued: 424.13m
  • Volume: 1,754,361
  • Market Cap: £291.80m

Deal with Barclays    Trade now with Barclays Stockbrokers

Niox Group Overview

Niox Group is a specialty biopharmaceutical company focused on the development and commercialisation of a range of immunotherapy product candidates for the treatment of allergy.

Key Personnel

CEO: Jonathan Emms
Chief Finance Officer: Michael R D Roller
Executive Chairman: Ian Johnson
Independent Non-Executive Director: Sharon Curran
Independent Non-Executive Director: Jo Le Couilliard
Senior Independent Director: Garry Watts
Non-Executive Dir: Robert (Rob) Graham Naylor, Nicholas Mills

Contact Details

Address: Hayakawa Building, Edmund Halley Road, Oxford Science Park, Oxford, United Kingdom, OX4 4GB
Phone: +44 (0)1865 405560
Fax: +44 (0)7092 987560
Website: http://www.niox.com/

Listings

Sector: Health Care(LSE)
Index: FTSE AIM All-Share, FTSE AIM 50, FTSE AIM 100
Overseas Listings: BATSLON:CIRL
ISIN: GB00BJVD3B28

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Niox Group Market Data

Currency UK Pounds
Share Price 68.80p
Change Today -3.20p
% Change -4.44 %
52 Week High 76.00p
52 Week Low 57.80p
Volume 1,754,361
Shares Issued 424.13m
Market Cap £291.80m

Niox Group Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
86.69% below the market average86.69% below the market average86.69% below the market average86.69% below the market average86.69% below the market average
69.7% below the sector average69.7% below the sector average69.7% below the sector average69.7% below the sector average69.7% below the sector average
Price Trend
85.73% above the market average85.73% above the market average85.73% above the market average85.73% above the market average85.73% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Income
73.78% below the market average73.78% below the market average73.78% below the market average73.78% below the market average73.78% below the market average
Sector averageSector averageSector averageSector averageSector average
Growth
31.19% above the market average31.19% above the market average31.19% above the market average31.19% above the market average31.19% above the market average
11.76% below the sector average11.76% below the sector average11.76% below the sector average11.76% below the sector average11.76% below the sector average

What The Brokers Say

Strong Buy 3
Buy 1
Neutral 0
Sell 0
Strong Sell 0
Total 4
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Niox Group Dividends

  Latest Previous
  Final Special
Ex-Div 23-May-24 17-Aug-23
Paid 24-Jun-24 15-Sep-23
Amount 1.00p 2.50p

Trades for 07-Apr-2025

Time Volume / Share Price
15:52 50,000 @ 69.38p
15:51 25,000 @ 69.39p
15:22 200 @ 70.00p
15:22 3,389 @ 69.40p
15:22 3,365 @ 69.40p

Niox Group Key Personnel

CEO Jonathan Emms

Top of Page